<DOC>
	<DOCNO>NCT01099527</DOCNO>
	<brief_summary>Capecitabine oral fluoropyrimidine show effective treatment metastatic gastric colorectal cancer patient . On basis capecitabine-based chemotherapy accept standard regimen gastric cancer , perform phase I/II study all-oral regimen RAD001 capecitabine refractory gastric cancer patient .</brief_summary>
	<brief_title>A Trial RAD001/Capecitabine Refractory Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>1 . Histologically cytologically proven gastric cancer patient 2 . Adequate organ function define follow criterion : A. Serum aspartate transaminase ( AST ; serum glutamic oxaloacetic transaminase ( SGOT ) ) serum alanine transaminase ( ALT ; serum glutamic pyruvic transaminase ( SGPT ) ) ≤ 2.5 x local laboratory upper limit normal ( ULN ) , AST ALT less equal 5 x ULN liver function abnormality due underlying malignancy B . Total serum bilirubin ≤ 3.0 mg/dL C. Absolute neutrophil count ( ANC ) ≥1500/µL D. Platelets ≥100,000/µL E. Hemoglobin ≥9.0 g/dL ( may transfuse erythropoietin treat ) F. Serum calcium ≤12.0 mg/dL G. Serum creatinine ≤1.5 x ULN 3 . Patients CNS metastasis must stable neurologic function without evidence CNS progression within 8 week 4 . Patients fail least two previous cytotoxic chemotherapy advance gastric cancer ( adjuvant treatment count one regimen receive &lt; 12 month start experimental treatment ) 5 . At least one measurable lesion RECIST criterion 6 . ECOG PS 02 7 . Patients informed consent 1 . Major surgery radiation therapy within 4 week start study treatment . 2 . History know carcinomatous meningitis , evidence symptomatic leptomeningeal disease screen CT MRI scan . 3 . Ongoing cardiac dysrhythmias NCI CTCAE grade ≥ 2 . 4 . Pregnancy breastfeed . 5 . Prior exposure study drug . 6 . Patients unable swallow oral medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>refractory</keyword>
	<keyword>metastatic</keyword>
</DOC>